| CTRI Number |
CTRI/2026/02/103550 [Registered on: 10/02/2026] Trial Registered Prospectively |
| Last Modified On: |
09/02/2026 |
| Post Graduate Thesis |
Yes |
| Type of Trial |
Observational |
|
Type of Study
|
Cross Sectional Study |
| Study Design |
Non-randomized, Active Controlled Trial |
|
Public Title of Study
|
A study of the clinical presentation, radiological findings, and causes of community acquired pneumonia at a tertiary care hospital |
|
Scientific Title of Study
|
Clinical, Radiological and Etiological Profile of Community-Acquired Pneumonia in a Tertiary Care Center |
| Trial Acronym |
NIL |
|
Secondary IDs if Any
|
| Secondary ID |
Identifier |
| NIL |
NIL |
|
|
Details of Principal Investigator or overall Trial Coordinator (multi-center study)
|
| Name |
Dr Gurinder Mohan |
| Designation |
Professor and HOD |
| Affiliation |
SGRDIMSR, Amritsar |
| Address |
Department of medicine, unit 1 , Sri guru ram das institute of medical sciences and research amritsar punjab
Amritsar PUNJAB 143501 India |
| Phone |
9815341556 |
| Fax |
|
| Email |
gmohan1.med@sgrdimsr.in |
|
Details of Contact Person Scientific Query
|
| Name |
Dr Gurinder Mohan |
| Designation |
Professor and HOD |
| Affiliation |
Sri guru ram das institute of medical sciences and research amritsar punjab |
| Address |
Department of medicine, sri guru ram das institute of medical sciences and research amritsar punjab
Amritsar PUNJAB 143501 India |
| Phone |
9815341556 |
| Fax |
|
| Email |
gmohan1.med@sgrdimsr.in |
|
Details of Contact Person Public Query
|
| Name |
Jashanjeet Singh |
| Designation |
Junior Resident |
| Affiliation |
Sri Guru Ram Das Institute of Medical Sciences and Research , Sri Amritsar , Punjab , India 143001 |
| Address |
Sri guru ram das institute of medical sciences and research amritsar punjab india
Amritsar PUNJAB 143501 India |
| Phone |
9646171497 |
| Fax |
|
| Email |
mail.jashan.jeet@gmail.com |
|
|
Source of Monetary or Material Support
|
| Department of Medicine
Sri Guru Ram Dass Institute of Medical Sciences and Research, Vallah, Amritsar, Punjab, India, 143001 |
|
|
Primary Sponsor
|
| Name |
Department of Medicine |
| Address |
Sri Guru Ram Dass Institute of Medical Sciences and Research Vallah Amritsar,Punjab,India,143001 |
| Type of Sponsor |
Private medical college |
|
|
Details of Secondary Sponsor
|
|
|
Countries of Recruitment
|
India |
|
Sites of Study
|
| No of Sites = 1 |
| Name of Principal
Investigator |
Name of Site |
Site Address |
Phone/Fax/Email |
| Dr Jashanjeet Singh |
Department of Medicine |
Department of medicine Sri Guru Ram Das Institute of Medical Sciences and Research Vallah Amritsar, Punjab, India, 143001 Amritsar PUNJAB |
9646171497
singhjashanjeet2812@gmail.com |
|
|
Details of Ethics Committee
|
| No of Ethics Committees= 1 |
| Name of Committee |
Approval Status |
| Institutional Ethics Committee |
Approved |
|
|
Regulatory Clearance Status from DCGI
|
|
|
Health Condition / Problems Studied
|
| Health Type |
Condition |
| Patients |
(1) ICD-10 Condition: J09-J18||Influenza and pneumonia, |
|
|
Intervention / Comparator Agent
|
| Type |
Name |
Details |
| Intervention |
Nil |
Nil |
| Intervention |
Nil |
Nil |
| Intervention |
Nil |
Nil |
|
|
Inclusion Criteria
|
| Age From |
18.00 Year(s) |
| Age To |
99.00 Year(s) |
| Gender |
Both |
| Details |
1. Adult patients (18 years)
2. Patients with clinical features suggestive of CAP (fever, cough with or without expectoration, pleuritic chest pain, dyspnea and altered sensorium.) and with Radiological evidence of pneumonia |
|
| ExclusionCriteria |
| Details |
1. Patients with hospital-acquired pneumonia.
2. Patients with ventilator-associated pneumonia.
3. Patients with healthcare-associated pneumonia.
3. Patients with active Pulmonary Tuberculosis.
4. Patients who have been hospitalized or institutionalized within the previous 90 |
|
|
Method of Generating Random Sequence
|
Not Applicable |
|
Method of Concealment
|
Not Applicable |
|
Blinding/Masking
|
Not Applicable |
|
Primary Outcome
|
| Outcome |
TimePoints |
| To determine most common clinical presentation , radiological findings, and causes of Community Acquired Pneumonia and initiating appropriate empirical antibiotic therapy, reducing complications, and improving patient outcomes. |
Baseline |
|
|
Secondary Outcome
|
| Outcome |
TimePoints |
| To analyze clinical outcomes such as duration of hospital stay, need for ICU admission, complications. |
Baseline |
|
|
Target Sample Size
|
Total Sample Size="100" Sample Size from India="100"
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" |
|
Phase of Trial
|
N/A |
|
Date of First Enrollment (India)
|
04/03/2026 |
| Date of Study Completion (India) |
Applicable only for Completed/Terminated trials |
| Date of First Enrollment (Global) |
Date Missing |
| Date of Study Completion (Global) |
Applicable only for Completed/Terminated trials |
|
Estimated Duration of Trial
|
Years="1" Months="6" Days="0" |
|
Recruitment Status of Trial (Global)
|
Not Applicable |
| Recruitment Status of Trial (India) |
Not Yet Recruiting |
|
Publication Details
|
N/A |
|
Individual Participant Data (IPD) Sharing Statement
|
Will individual participant data (IPD) be shared publicly (including data dictionaries)?
Response - NO
|
|
Brief Summary
|
Community-acquired pneumonia (CAP) is a major global cause of illness and death, especially in developing countries. It presents with symptoms such as fever, productive cough, breathlessness, chest pain, and systemic features, with severity ranging from mild disease to life-threatening illness. Radiologically, chest X-ray commonly shows lobar consolidation, bronchopneumonia, or interstitial infiltrates, while HRCT is useful in atypical or complicated cases. Etiologically, Streptococcus pneumoniae is the most common pathogen, though atypical bacteria, viral agents, gram-negative bacilli, and Staphylococcus aureus are increasingly recognized, particularly in severe cases. Clinical, radiological, and etiological profiling in tertiary care settings is essential for accurate diagnosis, appropriate empirical therapy, and improved patient outcomes. |